Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion -- A Multicenter, Prospective, Randomized, Open-label, Blinded End-point Trial

  • Guisong Wang

Press/Media

Period2 Jan 2026

Media coverage

1

Media coverage

  • TitleIntra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion -- A Multicenter, Prospective, Randomized, Open-label, Blinded End-point Trial
    Media name/outletNewsRx Hematology Daily
    Country/TerritoryUnited States
    Date2/01/26
    PersonsGuisong Wang
View all 1
View less